Dmitry Balyasny’s Array Biopharma Inc ARRY Stock Holding History

Dmitry Balyasny’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-190,000	Closed	-$2.81M	–	1952
2018 Q3	$2.81M	Buy	+190,000	New	+$2.91M	0.01%	887
2017 Q2	–	Sell	-570,000	Closed	-$5.1M	–	1900
2017 Q1	$5.1M	Buy	+570,000	New	+$6.06M	0.02%	698

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Dmitry Balyasny's ARRY Position: Q3 2019 in Review

Dmitry Balyasny sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 313,796 shares — an estimated $14.5M sold.

Dmitry Balyasny first reported a position in ARRY in Q2 2013 and held it in 19 quarters. The position peaked at $23.3M in Q4 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Dmitry Balyasny reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Dmitry Balyasny sold 313,796 Array Biopharma Inc shares in Q3 2019, an estimated $14.5M.
Dmitry Balyasny first reported a position in Array Biopharma Inc in Q2 2013 and held it in 19 quarters.
Dmitry Balyasny's Array Biopharma Inc position peaked at $23.3M in Q4 2017.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Balyasny Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.